Home/Filings/4/0001179110-03-010806
4//SEC Filing

HSIA DAVID C 4

Accession 0001179110-03-010806

CIK 0000884629other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 5:59 PM ET

Size

6.1 KB

Accession

0001179110-03-010806

Insider Transaction Report

Form 4
Period: 2003-11-13
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
  • Sale

    Common Stock, par value $0.0033

    2003-11-13$45.00/sh1,250$56,250597,814 total(indirect: By Trust)
Holdings
  • Common Stock, par value $0.0033

    60,000
  • Common Stock, par value $0.0033

    (indirect: By Trust)
    40,000
Footnotes (1)
  • [F1]1. The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans dated August 27, 2003.

Issuer

WATSON PHARMACEUTICALS INC

CIK 0000884629

Entity typeother

Related Parties

1
  • filerCIK 0001258176

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:59 PM ET
Size
6.1 KB